Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florent Wallet

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
American Journal of Hematology|August 4, 2020
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European centerPierre Sesques, Emmanuelle Ferrant, Violaine Safar, et al.
Obesity (Silver Spring, Md.)|May 9, 2021
BMI and pneumonia outcomes in critically ill covid-19 patients: An international multicenter studyMikael Chetboun, Violeta Raverdy, Julien Labreuche, et al.
The European Respiratory Journal|May 22, 2019
Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopyPhilippe R Bauer, Sylvie Chevret, Hemang Yadav, et al.
Intensive Care Medicine|March 4, 2015
Outcome of acute mesenteric ischemia in the intensive care unit: a retrospective, multicenter study of 780 casesMarc Leone, Carole Bechis, Karine Baumstarck, et al.
Intensive Care Medicine|March 13, 2015
Erratum to: Outcome of acute mesenteric ischemia in the intensive care unit: a retrospective, multicenter study of 780 casesMarc Leone, Carole Bechis, Karine Baumstarck, et al.
Scientific Reports|April 24, 2025
sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trialDavid M Smadja, Clément R Massonnaud, Aurélien Philippe, et al.
The Lancet. Respiratory Medicine|March 19, 2026
Epidemiology, ventilation, and outcomes of acute respiratory failure in immunocompromised patients from 103 intensive care units in 26 countries: a retrospective observational studyElie Azoulay, Colleen McEvoy, Pedro Castro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 28, 2021
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, et al.
The Lancet. Respiratory Medicine|November 29, 2021
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID studyJean-Pierre Gangneux, Eric Dannaoui, Arnaud Fekkar, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodiesAdrian Gervais, Astrid Marchal, Alexis Maillard, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
American Journal of Hematology|August 4, 2020
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European centerPierre Sesques, Emmanuelle Ferrant, Violaine Safar, et al.
Obesity (Silver Spring, Md.)|May 9, 2021
BMI and pneumonia outcomes in critically ill covid-19 patients: An international multicenter studyMikael Chetboun, Violeta Raverdy, Julien Labreuche, et al.
The European Respiratory Journal|May 22, 2019
Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopyPhilippe R Bauer, Sylvie Chevret, Hemang Yadav, et al.
Intensive Care Medicine|March 4, 2015
Outcome of acute mesenteric ischemia in the intensive care unit: a retrospective, multicenter study of 780 casesMarc Leone, Carole Bechis, Karine Baumstarck, et al.
Intensive Care Medicine|March 13, 2015
Erratum to: Outcome of acute mesenteric ischemia in the intensive care unit: a retrospective, multicenter study of 780 casesMarc Leone, Carole Bechis, Karine Baumstarck, et al.
Scientific Reports|April 24, 2025
sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trialDavid M Smadja, Clément R Massonnaud, Aurélien Philippe, et al.
The Lancet. Respiratory Medicine|March 19, 2026
Epidemiology, ventilation, and outcomes of acute respiratory failure in immunocompromised patients from 103 intensive care units in 26 countries: a retrospective observational studyElie Azoulay, Colleen McEvoy, Pedro Castro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 28, 2021
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, et al.
The Lancet. Respiratory Medicine|November 29, 2021
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID studyJean-Pierre Gangneux, Eric Dannaoui, Arnaud Fekkar, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodiesAdrian Gervais, Astrid Marchal, Alexis Maillard, et al.
Pageof 10